Discounts and the Impact of Shareholder Rights in Private Market Secondaries
Revelation Partners is commonly asked what our typical discount is. There is no “typical” discount, nor is discount a key driver of pricing. We have closed transactions at a premium to recent marks, and we have also closed transactions at discounts >50%. Discounts in secondary market transactions are not inputs but rather outputs of a […]
The Trump Administration’s Impact on Healthcare: A 2025 Outlook
With the 2024 election results finally in, it’s time to look ahead at the outlook for the healthcare industry under the new administration. We connected with Marwood Group, a leading healthcare advisory firm, who gave us the scoop on what we can expect under a Trump administration and Republican controlled Congress. Marwood’s Jennifer Meyers and […]
An Overview of Secondary Transactions – For Healthcare Companies
In this white paper, we cover: Watch a short video on what differentiates our secondary approach:
Stock Option Liquidity: A Guide for Private Company Employees
In this white paper, we cover: Watch a short video on this topic:
Navigating the Wave of Digital Disruptors in Behavioral Health
Investment in digital behavioral health companies has surged in recent years, driven by rising demand and favorable regulatory changes. We define this sector as tech-enabled practices who offer therapy, psychiatry, substance use disorder (“SUD”), and other behavioral health services. Typically, these services are offered through a telehealth platform but may also include in-person sessions or […]
Healthcare-Focused Secondaries Manager Revelation Partners Adds Kudu Investment Management as Strategic Partner
Revelation Partners (Revelation), a leading investment manager in the healthcare secondaries market, and Kudu Investment Management, LLC (Kudu), a provider of permanent capital solutions to independent asset and wealth managers worldwide, today announced that Kudu has made a minority investment in Revelation. Financial terms were not disclosed.
Bluesight Expands Capabilities Through Acquisition of Sectyr
Bluesight, the leading provider of Medication Intelligence™ solutions for health systems and hospital pharmacies, announced the acquisition of Sectyr, a top-tier compliance and audit management platform. This acquisition expands Bluesight’s portfolio to include robust 340B audit and compliance tools in response to growing demand from its customers.
Revelation Partners Deepens Healthcare Expertise with Two New Hires
Revelation Partners, the largest investment firm dedicated to healthcare secondaries, is pleased to announce the addition of two new investment team members. The firm welcomes Chris Bayliss as Vice President, along with Vicky Valverde as Associate. With over $1.5 billion of capital under management, Revelation Partners has evaluated over $1.3 billion of healthcare investment opportunities this year. Revelation Partners provides liquidity to parties […]
Stryker announces definitive agreement to acquire Vertos Medical, Inc., expanding interventional pain management solutions
Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire Vertos Medical Inc., a privately held company providing a minimally invasive solution for treating chronic lower back pain caused by lumbar spinal stenosis. “We are committed to helping customers restore patients’ quality of life with interventional solutions to address chronic […]
Amidst a Fight for Survival, Liquidity Tools Provide a Golden Opportunity to Emerging Managers in Healthcare
In mid-2023, we published a report on how a secondary strategy can assist GPs in raising capital. We touched upon the challenging fundraising environment that emerging managers face and how continuation vehicles are evolving to cater to the needs of emerging managers as they seek to establish a track record of distributions for LPs. In […]